Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009–2023, the Netherlands: a molecular epidemiological study
Journal of Clinical Microbiology · 2024
DOI: 10.1128/jcm.00766-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2024. Verfasst von Lidewij W Rümke und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Streptococcus pyogenes, Streptococcal Infections, Carrier State, Phylogeny. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Society of Clinical Microbiology and Infectious Diseases (ESCMID), St. Antonius Ziekenhuis (St. Antonius Hospital), Amsterdam UMC.
Abstract (Originalsprache)
Since 2022, many countries have reported an upsurge in invasive group A streptococcal (iGAS) infections. We explored whether changes in Streptococcus pyogenes carriage rates or emergence of strains with potentially altered virulence, such as emm 1 variants M1 UK and M1 DK , contributed to the 2022/2023 surge in the Netherlands. We determined emm (sub)type distribution for 2,698 invasive and 351 S . pyogenes carriage isolates collected between January 2009 and March 2023. Genetic evolution of emm 1 was analyzed by whole-genome sequencing of 497 emm 1 isolates. The nationwide iGAS upsurge coincided with a sharp increase of emm 1.0 from 18% (18/100) of invasive isolates in Q1 2022 to 58% (388/670) in Q1 2023 (Fisher’s exact test, P < 0.0001). M1 UK became dominant among invasive emm 1 isolates in 2016 and further expanded from 72% in Q1 2022 to 96% in Q1 2023. Phylogenetic comparison revealed evolution and clonal expansion of four new M1 UK clades in 2022/2023. DNase Spd1 and superantigen SpeC were acquired in 9% (46/497) of emm 1 isolates. S. pyogenes carriage rates and emm 1 proportions in carriage isolates remained stable during this surge, and the expansion of M1 UK in iGAS was not reflected in carriage isolates. During the 2022/2023 iGAS surge in the Netherlands, expansion of four new M1 UK clades was observed among invasive isolates, but not carriage isolates, suggesting increased virulence and fitness of M1 UK compared to contemporary M1 strains. The emergence of more virulent clades has important implications for public health strategies such as antibiotic prophylaxis for close contacts of iGAS patients. IMPORTANCE This study describes the molecular epidemiology of invasive group A streptococcal (iGAS) infections in the Netherlands based on >3,000 Streptococcus pyogenes isolates from both asymptomatic carriers and iGAS patients collected before, during, and after the COVID-19 pandemic period (2009–2023) and is the first to assess whether changes in carriage rates or carried emm types contributed to the alarming post-COVID-19 upsurge in iGAS infections. We show that the 2022/2023 iGAS surge coincided with a sharp increase of emm 1, particularly the toxicogenic M1 UK variant, in invasive isolates, but not in carriage isolates. These findings suggest that increased virulence and fitness of M1 UK likely contributes to an increased dissemination between hosts. The emergence of a more virulent and fit lineage has important implications for iGAS control interventions such as antibiotic prophylaxis for close contacts of iGAS patients and calls for a reappraisal of iGAS control interventions and guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands.
- Department of Medical Microbiology and Immunology, St. Antonius Hospital, Nieuwegein, the Netherlands.
- Department of Medical Microbiology and Infection Prevention, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.
- Department of Medical Microbiology and Immunology, Diakonessenhuis, Utrecht, the Netherlands.
- National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
- Netherlands Reference Laboratory for Bacterial Meningitis (NRLBM), Amsterdam UMC location AMC, Amsterdam, the Netherlands.
ORCID-Profile: Nina M van Sorge
Förderung
- European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
- St. Antonius Ziekenhuis (St. Antonius Hospital)
- Amsterdam UMC
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)
Zitieren
APA
Rümke, L. W., Davies, M. A., Vestjens, S. M. T., van der Putten, B. C. L., Bril-Keijzers, W. C. M., van Houten, M. A., Rots, N. Y., Wijmenga-Monsuur, A. J., van der Ende, A., de Gier, B., Vlaminckx, B. J. M., & van Sorge, N. M. (2024). Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009–2023, the Netherlands: a molecular epidemiological study. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.00766-24
Vancouver
Rümke LW, Davies MA, Vestjens SMT, van der Putten BCL, Bril-Keijzers WCM, van Houten MA, et al. Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009–2023, the Netherlands: a molecular epidemiological study. Journal of Clinical Microbiology. 2024. doi:10.1128/jcm.00766-24
BibTeX
@article{Rmke2024,
author = {Rümke, Lidewij W and Davies, Matthew A and Vestjens, Stefan M T and van der Putten, Boas C L and Bril-Keijzers, Wendy C M and van Houten, Marlies A and Rots, Nynke Y and Wijmenga-Monsuur, Alienke J and van der Ende, Arie and de Gier, Brechje and Vlaminckx, Bart J M and van Sorge, Nina M},
title = {Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009–2023, the Netherlands: a molecular epidemiological study},
journal = {Journal of Clinical Microbiology},
year = {2024},
doi = {10.1128/jcm.00766-24}
}
EUVIMED